• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Fibrinolytic activity of the urine during chronic glomerulonephritis and amyloidosis].

作者信息

Podorol'skaia L V, Andreenko G V, Poliantseva L R, Bumblite I D

机构信息

Moscow State University, Biological Department.

出版信息

Vopr Med Khim. 1999 Mar-Apr;45(2):158-64.

PMID:10378306
Abstract

Correlative interconnections between plasminogen activator (PA) activity (fibrin plate method) and level of urokinase antigen (Ag UAP) and tissue PA antigen (Ag TAP) in urine and blood (ELISA) were studied in 60 patients with chronic glomerulonephritis (CGN) and 38 patients with amyloidosis. The high degree of positive correlation between blood and urine initial PA activity and Ag UAP content was found. This suggests the possible leading role of UAP in formation of the basal fluctuations of fibrinolytic activity in blood and urine. High degree of correlation--r = +0.84 and p < 0.001--was found between blood Ag UAP and urine Ag TAP in amyloidosis only. The functional protein loading probe revealed great importance of high urine and blood AP activity in realizing of ultrafiltration renal process--in CGN and amyloidosis.

摘要

相似文献

1
[Fibrinolytic activity of the urine during chronic glomerulonephritis and amyloidosis].
Vopr Med Khim. 1999 Mar-Apr;45(2):158-64.
2
[Urokinase as a blood and urine plasminogen activator in chronic glomerulonephritis and amyloidosis].[尿激酶作为慢性肾小球肾炎和淀粉样变性中血液及尿液纤溶酶原激活剂的研究]
Vestn Ross Akad Med Nauk. 1999(2):58-61.
3
[Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].[人类原发性肾小球疾病中的肾小球内凝血与纤溶]
Nihon Jinzo Gakkai Shi. 1991 Aug;33(8):719-29.
4
[The effect of a protein loading test on the fibrinolytic system in patients with chronic glomerulonephritis and amyloidosis].[蛋白质负荷试验对慢性肾小球肾炎和淀粉样变性患者纤溶系统的影响]
Ter Arkh. 1992;64(6):19-21.
5
[Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].[内皮功能障碍和血液流变学紊乱标志物对评估慢性肾小球肾炎活动度和预后的意义]
Ter Arkh. 2010;82(1):47-51.
6
[Activators and inhibitors of fibrinolysis in chronic glomerulonephritis and amyloidosis].[慢性肾小球肾炎和淀粉样变性中纤维蛋白溶解的激活剂和抑制剂]
Vopr Med Khim. 1996 Oct-Dec;42(4):322-7.
7
Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.某些骨髓增殖性综合征中的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及纤溶酶原激活剂抑制剂(PAI - 1和PAI - 2)
Med Sci Monit. 2000 Jul-Aug;6(4):684-91.
8
[Lipiduria in the nephrotic syndrome].[肾病综合征中的脂尿]
Ter Arkh. 1992;64(6):16-8.
9
Fibrinolysis system in patients with bronchial asthma.支气管哮喘患者的纤溶系统
Med Sci Monit. 2000 Jan-Feb;6(1):103-7.
10
Plasminogen activator in nephrotic syndrome.肾病综合征中的纤溶酶原激活物。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(3):351-5.